GeneTether Therapeutics Inc. (GTTX.CN)
- Previous Close
0.0450 - Open
0.0000 - Bid 0.0150 x --
- Ask 0.0650 x --
- Day's Range
0.0450 - 0.0450 - 52 Week Range
0.0150 - 0.0500 - Volume
0 - Avg. Volume
563 - Market Cap (intraday)
1.744M - Beta (5Y Monthly) -0.44
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
GeneTether Therapeutics Inc., a genetic medicines company, focuses on developing gene editing therapies to enhance the efficiency of genome editing technologies. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada.
genetether.comRelated News
Performance Overview: GTTX.CN
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GTTX.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GTTX.CN
Valuation Measures
Market Cap
1.74M
Enterprise Value
1.85M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.93
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-2.47
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-27.84%
Return on Equity (ttm)
-42.64%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-688.36k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.36M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-236.79k
Company Insights: GTTX.CN
GTTX.CN does not have Company Insights